This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,421.17, is for the delivery of 4566912303 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 4, 2025. This award is associated with a larger Indefinite Delivery Contract...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of INLYTA 5 MG TABLET 60S, a prescription medication. The firm-fixed-price delivery order, valued at $11,039.62, has an ultimate completion date of October 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide INLYTA 5 MG TABLET 60S medication. The firm-fixed-price delivery order has a ceiling value of $11,039.62 and an ultimate completion date of August 16, 2024. This award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award, valued at $22,079.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564598972 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2024 and was awarded on May 14, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds...
This federal contract award, valued at $22,079.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of INLYTA 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 16, 2024. This award is a firm fixed price delivery order and does not have a set-aside designation. In addition to this specific delivery order,...
This federal contract award is for the delivery of the pharmaceutical product INLYTA 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $11,421.17. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,421.17 firm fixed-price delivery order is for the supply of 4566745148 INLYTA 5 MG TABLET 60S, with a performance period ending on January 9, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,421.17, is a Firm Fixed Price Delivery Order for the supply of INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on February 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,079.24, is for the delivery of 4566135586 - INLYTA 5 MG TABLET 60S. It is a firm fixed-price delivery order contract with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $11,458.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...